Exploration of the mode of action and beta-cell regenerating effect of ER stress regulating MANF in mouse diabetes models

Description of the granted funding

Diabetes mellitus (DM) is characterized by hyperglycemia caused by the inability of pancreatic beta- cells to maintain sufficient levels of circulating insulin. T1 diabetes (T1D) is caused by autoimmune destruction of beta-cells whereas insulin resistance and progressive beta-cell death characterizes T2D. About 425 million people have DM and its incidence is increasing rapidly. The current medications alleviate symptoms but cannot prevent devastating vascular complications of DM. Thus, one strategy for improving DM therapies is to define and validate novel approaches to protect beta-cells and activate their regeneration. We have found that mesencephalic astrocyte-derived neurotrophic factor (MANF) is needed for the survival and proliferation of beta-cells in mice and has a regenerative effect on human and mouse beta-cells in culture. Our main objectives are to elucidate the mode of MANF action in beta-cells and to evaluate the therapeutic potential for MANF in mouse models of DM.
Show more

Starting year

2020

End year

2024

Granted funding

Maria Lindahl Orcid -palvelun logo
499 957 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Other information

Funding decision number

333974

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

diabetes, medicine, metabolic diseases